Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Partnership for change: improving the medication experience

M J Boyer, C Lillis

    NLN Publications
    |March 1, 1993
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of physical activity on fatigue and quality of life in people with advanced lung cancer: a randomized controlled trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer.

    British journal of cancer·2015
    Same author

    Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer.

    British journal of cancer·2014
    Same author

    Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer.

    British journal of cancer·2014
    Same author

    Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29.

    European journal of cancer (Oxford, England : 1990)·2013
    Same author

    Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer.

    Journal of clinical pathology·2013